Dahu Health Industry Co., Ltd. (SHA:600257)

Dahu Health Industry Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	5.57	5.07	-76.95	-8.16	-71.5	-180.12
Depreciation & Amortization	61.01	61.01	62.64	62.62	62.3	53.69
Other Amortization	28.05	28.05	26.65	28.02	24.18	19.85
Loss (Gain) From Sale of Assets	-0.57	-0.57	-2.28	-6.44	-0.41	63.36
Asset Writedown & Restructuring Costs	2.36	2.36	27.66	4.65	37.27	126.61
Loss (Gain) From Sale of Investments	-7.55	-7.55	3.72	2.65	6.97	-3.27
Provision & Write-off of Bad Debts	-2.11	-2.11	6.41	6.28	20.22	5.34
Other Operating Activities	35.9	58.33	58.13	66.48	41.89	71.69
Change in Accounts Receivable	45.3	45.3	-34.88	0.89	40.64	-13.44
Change in Inventory	27.37	27.37	9.2	65.81	-34.82	39.59
Change in Accounts Payable	-1.07	-1.07	-29.94	-51.12	-20.46	-80.08
Operating Cash Flow	196.05	217.99	67.45	162.09	97.87	96.42
Operating Cash Flow Growth	46.69%	223.18%	-58.39%	65.62%	1.50%	-

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Capital Expenditures	-42.12	-9.7	-21.34	-19.2	-61.81	-79.69
Sale of Property, Plant & Equipment	0.1	0.27	7.15	9.37	0.73	0.95
Cash Acquisitions	-22.93	-	-	-	-15	-
Divestitures	-	-	0.17	7.58	0	-
Investment in Securities	-23.05	-3.48	-13.57	12.08	12.19	-31.76
Other Investing Activities	41.26	6.3	0.46	-	0.62	2.72
Investing Cash Flow	-46.74	-6.62	-27.13	9.83	-63.27	-107.78

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Long-Term Debt Issued	-	273	210	322.2	335.2	535.4
Long-Term Debt Repaid	-	-337.76	-382.8	-370.43	-446.91	-375.5
Net Debt Issued (Repaid)	-86.77	-64.76	-172.8	-48.23	-111.71	159.9
Common Dividends Paid	-10.84	-11.71	-15.85	-18.98	-21.15	-38.41
Other Financing Activities	-7.49	-4.35	-0.75	0.44	-0.06	-0.08
Financing Cash Flow	-105.1	-80.81	-189.4	-66.77	-132.93	121.41

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Cash Flow	44.21	130.56	-149.08	105.15	-98.34	110.05

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Free Cash Flow	153.93	208.28	46.12	142.89	36.05	16.73
Free Cash Flow Growth	31.37%	351.65%	-67.73%	296.30%	115.48%	-
Free Cash Flow Margin	16.76%	22.64%	4.42%	11.97%	3.29%	1.29%
Free Cash Flow Per Share	0.30	0.41	0.10	0.35	0.08	0.03
Levered Free Cash Flow	76.89	181.2	40.25	133.14	-23.76	59.04
Unlevered Free Cash Flow	97.4	202.24	63.32	159.15	3.62	85.32

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash Income Tax Paid	59.83	63.98	68.89	87.59	68.34	58.7
Change in Working Capital	73.4	73.4	-38.53	6	-23.06	-60.72

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 31, 2026

Data Sources Report a data error